LEGIONELLA
Historical: Legionaire’s dz first described in 1976
American Legion convention in Philadelphia hotel.
Epidemiology: 2-15% of all com-acq pneumon req
hospitalization. (top 3-4 bugs) Only 3% correctly dxd. Legionella pheumonia more likely to be
severe by VS and CXR, more likely to req ICU.
RISK FACTORS: cig smoking,
chronic lung dz, immunosuppression (esp. steroids), surgery (esp transplant).
MODE OF TRANSMISSION:
inhalation of aerosols (cooling towers, respiratory therapy equip,
whirlpool baths) or microaspiration of contaminated water (head and neck surg,
NG tubes).
Virulence
factors: 40 species,
less than ˝ cause dz in humans. L
pneumophila most virulent (90% of cases).
14 serogroups, serogroup 1 accounts for > 80% of cases. Flagella linked w/ virulence.
Clnical
Manifestations: Broad
spectrum of illness from mild cough and low-grade fever to stupor, resp and
multi-organ failure. Early sxs
non-specific: fever, malaise, myalgias,
anorexia, HA. T often > 40. Cough slightly productive sometimes
hemoptysis. CP, sometimes
pleuritic. GI sxs: watery diarrhea 20-40%. CV:
relative bradycardia. FEN: Hyponatremia (Na < 130). Extrapulm:
myocarditis, pericarditis, postcardiotomy synd, prosthetic valve
endocarditis, sinusitis, cellulitis, pancreatitis, peritonitis, pyelo.
Labs:
1. Cx: most definitive. Charcoal-yeast extract medium. Many labs do not cx properly. Sputum cx may be revealing regardless of
quality of specimen.
2. DFA:
sensitivity < cx. Monoclonal
test superior.
3. Legionella Urinary Antigen: Sens 70%, Spec 100%. Sens improved by ultrafiltration of
urine. Remains positive for weeks on
abx. Less than 10% positive after 60
days post rx. Only detects serogroup
1.
4. Serologic tests: 4-fold increase in convalescent titers. Must include IgM and IgG.
5. PCR:
Highly specific, no more senstitive than cx.
6. Pleural fluid: send for cx and LUA.
Treatment:
1. Erythro- historical drug of choice
2. Azithro- greater intracellular and lung
penetration.
3. Quniolones- annecdotal support, esp
cipro.
4. Rifampin- rec in combination w/ macrolide or
quinolone in severly ill pts.
5. Tetracycline, imipenem. Bactrim, oflox,
clinda reported.